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The analgesic efficacy of APS is
equal to TENS. Pilot study of
patients with chronic pain in
the musculoskeletal disorders
Abstract
Background. Pain accompanying the musculoskeletal disorders appears to be one of the most frequent
medical problem. It concerns both office workers who sit for long hours in one position and people who do
hard physical labor. The pain is usually difficult to treat. Change of the life style, pharmacotherapy and
different techniques of physical therapy are all important. APS-therapy and TENS are the physical methods
based on therapeutic use of the electrical current. They both can be very useful in many pain-related
disorders, providing fast relief of symptoms. The aim of this pilot clinical study was to compare the analgesic
efficacy of APS-therapy and TENS in chronic pain due to musculoskeletal disorders.
Material and methods. The study involved 25 patients with musculoskeletal disorders who suffered from
chronic pain. Thirteen of them were treated by the use of TENS and 12  by APS. In the TENS group each
patient received treatment for 2 weeks and in the APS  for 3 weeks. TENS was administered for a period of
60 minutes while APS for 16 minutes, both 5 times a week. The treatment was given by portable units, that
generated an APS waveform and TENS current. NRS evaluation was performed for 3 days of pre-treatment
period, before each treatment, which reflected the pain situation of the previous 24 hours, and once daily
for 2 weeks after the treatment.
Results. The study showed that both methods have almost equal analgesic efficacy. Comparing with the
initial period, NRS significantly decreased during the treatment and observation. The difference between
the mean values of NRS score in TENS and APS was not of the statistical significance.
Conclusion. Both TENS and APS-therapy may be the effective methods of nonpharmacological treatment of
chronic pain in the musculoskeletal disorders.
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Introduction
Chronic pain in the musculoskeletal disorders is
quite common and causes a lot of suffering and
disability. Analgesia achieved by pharmacotherapy
is frequently unsatisfactory, and the presence of
adverse reactions, particularly after non-steroidal
anti-inflammatory drugs, is well known. Therefore
many patients need physical methods such as TENS
(Transcutaneous Electrical Nerve Stimulation) or APS-
-therapy (Action Potential Simulation). Indeed, elec-
trotherapy may be the main or a complementary
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method for treating many pain related disorders,
providing fast relief of symptoms.
Conventional TENS was originally developed as
a way of controlling pain according to the gate
theory, in which selective stimulation of certain
nerve fibres should block, or close the gate on
signals carrying pain impulses to the brain [1]. TENS
has been reported to be highly effective in the man-
agement of a wide variety of acute and chronic
syndromes [25].
APS-therapy falls under the broad definition of
MET (Microcurrent Electrical Stimulation). This type
of electrical modality uses an electrical current of
less than 1 mA, which is measured in the microam-
perage range. The APS-therapy produces a current
that is claimed to stimulate an action potential in
the neuron. According to the Arndt-Schultz Law,
weak stimuli increase physiological activity [6]. In-
vestigation into the physiological mechanisms has
shown that these sub-threshold currents cause the
following effects: changes in the cell wall perme-
ability, increase of the intracellular concentrations
of Ca2+ and adenosine triphosphate (ATP) produc-
tion, stimulation of protein synthesis and increase
of fibroblast activity [7]. The APS device was invent-
ed and designed by Lubbe in 1991 in South Africa,
and marketed in 1994 even without published stud-
ies in peer-reviewed journals [7]. Publications on
APS-therapy are still very rare and there is a great
need of formal control studies.
A controlled trial using APS-therapy and TENS to
treat the pain of osteoarthritis of the knee was re-
ported by Berger [8]. In this study both methods of
electrotherapy proved to be equally beneficial in the
relief of stiffness and pain, especially occurring at
night [8]. Other authors who studied the usage of
APS-therapy in chronic and acute post-traumatic pain
conditions (low back pain, tennis elbow, sports inju-
ries, shoulder pain, arthritis) indicate that APS-thera-
py produces 4080% pain relief after 515 treatment
sessions [913]. Our previous study showed that APS-
therapy significantly decreased pain due to different
musculoskeletal disorders [14]. In this study we com-
pare analgesic efficacy of APS and TENS.
Material and methods
The study protocol was accepted by the Ethics
Committee of the Nicolaus Copernicus University,
Collegium Medicum in Bydgoszcz in Poland. Before
the trial each patient was examined by the physician
and signed an informed consent. The study includ-
ed patients with chronic pain due to musculoskele-
tal disorders with average pain intensity not less
than 3 measured in NRS (Numerical Rating Scale;
values from 0 to 10; 0 means no pain, 10  over-
whelming pain). Patients had to be over 18 and
able to estimate pain intensity.
The study involved 25 patients (TENS group, n = 13;
APS group, n = 12) with musculoskeletal disorders,
who suffered from chronic pain. The demographic
and clinical data of the investigated subjects are
presented in the Table 1. Each patient received
2 weeks time treatment in TENS group and 3 weeks
in APS group. The current was administered for
a period of 60 minutes in TENS group and 16 minutes
in APS group, both 5 times a week. The treatment was
given by portable units. Technical specifications of
the TENS and APS-therapy device, information about
stimulation parameters and electrodes placements
are presented in the Table 2. Numerical Rating Scale
evaluation was performed for 3 days of pre-treat-
ment period, before each treatment, which reflect-
ed the pain situation of the previous 24 hours, and
once daily for 2 weeks after treatment.
Statistical analysis was made using licensed ver-
sion of STATISTICA 5.0 PL software for Windows.
The data were presented as the mean – standard
deviation of NRS values, calculated separately for
the every study phases: initial observation, treat-
ment phase and observation period after therapy
(Fig. 1). The comparisons of the respective values
were made by ANOVA method with three repeti-
tions and Schefe post hoc test.
Results
The comparison of mean NRS values for: initial
and therapy phases as well as observation period
after TENS and APS treatment were presented in
Figure 1. The comparison of mean summary NRS
Table 1. Patients characteristics





Degenerative joint disease 11
Painful Shoulder Syndrome 10
Rheumatoid arthritis 2





NSAIDs  Non-steroidal anti-flammatory drugs
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values for the whole period of the study were pre-
sented in Figure 2.
The study showed that both methods have al-
most identical analgesic efficacy. Comparing with
the initial period NRS significantly decreased during
the treatment and observation. The difference be-
tween the mean values of NRS score in TENS and
APS was not of statistical significance. During the
treatment no side effects were observed.
Discussion
The pilot study showed similar analgesic efficacy
of two physical methods: TENS and APS. Consider-
ing the fact that after 14 days of TENS treatment
and 21 days of APS the effects were identical, TENS
seems to be more clinically useful. However, the
duration of each session (TENS  60 min and APS
 16 min) and physiological mechanisms causing
analgesic effect should be taken into consideration.
The mechanisms are connected with the time of
maintaining decreased NRS scores. TENS is the meth-
od which cure pain only symptomatically while
APS is a causal treatment of pain. Increase of ATP
generation after microcurrent stimulation in rat skin
models was reported by Cheng [15]. ATP plays an
essential role in the inter-body communication (gen-
eration of nerve impulses for communication and
control purposes), muscle contraction (e.g. during
walking, breathing etc.), nerve conduction, trans-
port, growth etc. That is the reason that APS-thera-
py can be used in pain relief, breakdown of inflam-
mation and wound healing. To establish which post
stimulation analgesic effect lasts longer the obser-
vation period should be prolonged.
The study suggests that both physical methods
can be used as an alternative to drugs or comple-
mentary methods for chronic pain management. We
showed that they significantly decrease pain due to
different musculoskeletal disorders. Furthermore,
these kinds of treatment are cheap and cause no
side effects. Another advantage of these methods is
the fact that the treatment session takes a short
Table 2. Transcutaneous Electrical Nerve Stimulation and Action Potential Simulation parameters
Stimulation parameters Electrodes placements Wave form
TENS
Frequency = 80100 Hz One channel,
Pulse width = 100200 µs electrodes were placed
Intensity  up to evoke the painless paresthesia to surround the target
Treatment duration = 60 min area
APS
Frequency = 150 Hz Two channels,
Pulse width = 800 ms electrodes were placed
Intensity = 0.51.5 mA to surround the target
Treatment duration = 16 min area
TENS  Transcutaneous Electrical Nerve Stimulation; APS  Action Potential Simulation
Figure 1. The comparison of mean NRS (Numerical Rat-
ing Scale) values for: initial and therapy phases as well
as observation period after Transcutaneous Electrical
Nerve Stimulation and Action Potential Simulation treat-
ment; ANOVA F (2.46) = 0.01; p = 0.98; TENS  Tran-
scutaneous Electrical Nerve Stimulation; APS  Action
Potential Simulation
Figure 2. The comparison of mean summary NRS (Nu-
merical Rating Scale) values for the whole period of the
study; ANOVA F (1.23) = 0; p = 0.99; TENS  Transcu-
taneous Electrical Nerve Stimulation; APS  Action Po-
tential Simulation
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time (approximately 16 minutes once a day for 3
weeks in APS, 60 minutes once a day for 2 weeks in
TENS) and in many cases can be applied by the
patient himself at home.
The results of this pilot study indicate that it ought
to be continued in a bigger group of patients.
Conclusion
APS-therapy and TENS are useful non-pharma-
cological therapeutic modalities of comparable effi-
cacies for the treatment of chronic pain in muscu-
loskeletal disorders.
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